期刊文献+

三冲多联疗法治疗重症狼疮性肾炎的疗效观察 被引量:8

Efficacy of Three Pulse Therapy Combine with Multidrug Treatment on Patients with Severe Lupus Nephritis
下载PDF
导出
摘要 目的:探讨三冲多联疗法治疗重症狼疮性肾炎的疗效。方法:选择确诊为重症狼疮性肾炎的患者48例,随机分为两组。对照组24例,给予激素、环磷酰胺及抗凝治疗,实验组24例,应用激素、环磷酰胺、丙种球蛋白冲击联合抗凝药物、血液净化、并辨证地配合中医中药疗法。比较两组患者总体缓解情况,治疗前后生化指标、SLEDAI评分、免疫指标等,并分别记录不良反应。结果:实验组患者总体缓解率(91.6%)显著优于对照组(75%),两组比较差异具有统计学意义(P<0.05)。实验组继发感染,柯氏征,神经精神症状及死亡率[分别为8.3%(2例),41.7%(10例),29.2%(7例),4.2%(1例)],显著低于对照组[分别为25.0%(6例),66.7%(16例),54.2%(13例),12.5%(3例)],差异具有统计学意义(P<0.05)。实验组治疗后(1月、3月、6月)尿蛋白、尿红细胞、Cr和SLEDAI评分显著低于对照组,Hb、PLT和Alb显著高于对照组,两组比较差异均有统计学意义(P<0.05)。实验组治疗后ANA滴度、抗dsDNA阳性率显著低于对照组,差异具有统计学意义(P<0.05)。结论:三冲多联疗法对重症狼疮性肾炎患者的疗效显著,具有借鉴意义。 Objective:To investigate the efficacy of three pulse therapy combine with muhidrug treatment on patients with severe lupus nephritis. Methods:The 48 patients with severe lupus nephritis were randomly divided into control group and treatment group. Patients in control group were given treatment of corticosteroids, cyclophosphamide and anticoagulants, and those in treatment group were accepted treatment of corticosteroids, cyclophosphamide, immunoglobulin, anticoagulants, blood purification and Chinese medicine. Compared overall relief of patients' condition, biochemical indices, SLEDAI score, and immune indicators before and after treatment, and the adverse reactions are recorded respectively. Results:The total efficiency of treatment group was 91.6%, higher than control group 75%, the difference was statistically significant (P 〈 0.05 ). The rate of adverse reactions ( infection, cushing syn- dromes, neuropsychic symptom) and death rate of treatment group [8.3% (2 cases) ,41.7% ( 10 cases) ,29.2% (7 cases), 4.2% (1 cases)] were much less than that of control group [ 25.0% (6 cases),66.7% (16 cases),54.2% (13 cases), 12.5% (3 ca- ses) ]. The difference were statistically significant ( all P 〈 0.05). Compared with the control group, 24 hours urine protein quantiti- ty, urine RBC, creatinine and the SLEDAI scorces of treatment group after 1,3and 6 months where obviously decreased, hemoglobin, platelet and albumin were obviously increased, the difference was statistically significant ( all P 〈 0.05 ). The positive rate of ANA and anti ds - DNA antibody of treatment group after 1,3 and 6 months significantly lower than control group, the difference was statistically ( all P 〈 0.05 ). Conclusion: The efficacy of three pulse therapy for severe lupus nephritis patients is significant, with reference.
作者 尤燕华 李彩凤 胡玉清 许树根 梁萌 YOU Yanhua;LI Caifeng;HU Yuqing(Department of nephrology,Chenggong Hospital,Xiamen University,Xiamen 361000)
出处 《中国中西医结合肾病杂志》 2018年第5期399-402,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 厦门市科技计划项目(No.3502Z20154043)
关键词 激素 环磷酰胺重症狼疮性肾炎 丙种球蛋白 血液净化 Corticostcroids Cyclophosphamide Severe refractory Immunoglobulin Blood purification
  • 相关文献

参考文献5

二级参考文献53

  • 1季大玺,龚德华,任冰,徐斌,刘芸,张一丹,谢红浪,陶静,胡伟新,刘志红,黎磊石.免疫吸附的临床应用及疗效[J].肾脏病与透析肾移植杂志,2004,13(5):408-413. 被引量:44
  • 2时振声.时氏中医肾脏病学[M].北京:中国医药科技出版社,1996,134..
  • 3叶任高,中华肾脏病杂志,1991年,7卷,147页
  • 4蒋伟,江苏医药,1987年,12卷,650页
  • 5Paulus HE,Egger MJ,Wand JR,et al.Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs based on findings in patients with placebo.Arthritis Rheum,1990,33:477-484.
  • 6Caldwell J,Gendreau RM,Furst D,et al.A pilot study using a staph protein A column (Prosorba) to treat refractory rheumatoid arthritis.J Rheumatol,1999,26:167-172.
  • 7Felson DT,LaValley MP,Baldassare AR,et al.The Prosorba column for treatment of refractory rheumatoid arthritis:a randomized,doubleblind,sham-controlled trial.Arhriti Rheum,1999,42:2153-2159.
  • 8Felson DT,Anderson JJ,Boers M,et al.American college of rheumatology preliminary defination of improvement in rheumatoid arthritis.Arthritis Rheum,1995,38:727 -735.
  • 9Laczika K,Knapp S,Derfler K,et al.Immunoadsorption in Goodpasture' s syndrome.Am J Kidney Dis,2000,36(2):392 -395.
  • 10Higgins RM,Bevan DJ,Carey BS,et al.Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation.Lancet,1996,348 (9036):1208-1211.

共引文献51

同被引文献115

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部